Johnny Suijker

495 total citations
11 papers, 374 citations indexed

About

Johnny Suijker is a scholar working on Cancer Research, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johnny Suijker has authored 11 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cancer Research, 4 papers in Rheumatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johnny Suijker's work include Bone Tumor Diagnosis and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer-related molecular mechanisms research (3 papers). Johnny Suijker is often cited by papers focused on Bone Tumor Diagnosis and Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer-related molecular mechanisms research (3 papers). Johnny Suijker collaborates with scholars based in Netherlands, United States and Germany. Johnny Suijker's co-authors include Judith V.M.G. Bovée, Anne‐Marie Cleton-Jansen, Inge H. Briaire‐de Bruijn, Norma Frizzell, Attje S. Hoekstra, Pauline M. Wijers‐Koster, Jan Oosting, Erik H.J. Danen, Helene Roelofs and Hans J. Baelde and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Johnny Suijker

11 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnny Suijker Netherlands 8 147 144 129 128 49 11 374
Sakura Tamaki Japan 8 72 0.5× 97 0.7× 73 0.6× 149 1.2× 55 1.1× 8 312
Pauline M. Wijers‐Koster Netherlands 10 110 0.7× 162 1.1× 130 1.0× 163 1.3× 9 0.2× 14 427
Hiroo Mizobuchi Japan 10 84 0.6× 159 1.1× 51 0.4× 134 1.0× 16 0.3× 19 356
Satoshi Kamura Japan 9 83 0.6× 119 0.8× 50 0.4× 162 1.3× 14 0.3× 17 394
Robert W. Cowan Canada 12 126 0.9× 199 1.4× 248 1.9× 138 1.1× 20 0.4× 20 496
Masaki Shibayama Japan 8 66 0.4× 84 0.6× 63 0.5× 476 3.7× 16 0.3× 10 610
Lisa J. Guerrero United States 10 99 0.7× 29 0.2× 103 0.8× 154 1.2× 11 0.2× 11 370
Lingyang Hua China 15 90 0.6× 73 0.5× 58 0.4× 176 1.4× 11 0.2× 49 586
Hammurabi Bartuma Sweden 13 38 0.3× 150 1.0× 97 0.8× 258 2.0× 28 0.6× 16 498
Hideki Yoshikawa Japan 7 67 0.5× 180 1.3× 64 0.5× 149 1.2× 18 0.4× 14 377

Countries citing papers authored by Johnny Suijker

Since Specialization
Citations

This map shows the geographic impact of Johnny Suijker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnny Suijker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnny Suijker more than expected).

Fields of papers citing papers by Johnny Suijker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnny Suijker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnny Suijker. The network helps show where Johnny Suijker may publish in the future.

Co-authorship network of co-authors of Johnny Suijker

This figure shows the co-authorship network connecting the top 25 collaborators of Johnny Suijker. A scholar is included among the top collaborators of Johnny Suijker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnny Suijker. Johnny Suijker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Queiroz, Karla, Chee Ping Ng, Thomas Olivier, et al.. (2023). Phenotypic screening in Organ-on-a-Chip systems: a 1537 kinase inhibitor library screen on a 3D angiogenesis assay. Angiogenesis. 27(1). 37–49. 16 indexed citations
2.
Fischer, David F., Sipke Dijkstra, Johnny Suijker, et al.. (2022). Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation. PLoS ONE. 17(4). e0266812–e0266812. 3 indexed citations
3.
Suijker, Johnny, Karla Queiroz, Thomas Olivier, et al.. (2021). A Microfluidic 3D Endothelium-on-a-Chip Model to Study Transendothelial Migration of T Cells in Health and Disease. International Journal of Molecular Sciences. 22(15). 8234–8234. 56 indexed citations
4.
Spelier, Sacha, Johnny Suijker, Henriëtte L. Lanz, et al.. (2021). Abstract 2777: Modelling T Cell-Vasculature co-culture in a high-throughput microfluidic platform. Cancer Research. 81(13_Supplement). 2777–2777. 1 indexed citations
5.
Cleven, Arjen H.G., Johnny Suijker, Georgios Agrogiannis, et al.. (2017). IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas. SHILAP Revista de lepidopterología. 7(1). 8–8. 47 indexed citations
6.
Peterse, Elisabeth F.P., Brendy E.W.M. van den Akker, Jan Oosting, et al.. (2017). NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma. Molecular Cancer Research. 15(12). 1714–1721. 37 indexed citations
7.
Jong, Yvonne de, Adrián Mariño‐Enríquez, Daniëlle de Jong, et al.. (2016). Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line. Laboratory Investigation. 96(10). 1128–1137. 27 indexed citations
8.
Suijker, Johnny, Jan Oosting, Eduard A. Struys, et al.. (2015). Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines. Oncotarget. 6(14). 12505–12519. 71 indexed citations
9.
Suijker, Johnny, Hans J. Baelde, Helene Roelofs, Anne‐Marie Cleton-Jansen, & Judith V.M.G. Bovée. (2015). The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo. Oncotarget. 6(17). 14832–14842. 33 indexed citations
10.
Hoekstra, Attje S., Inge H. Briaire‐de Bruijn, Cor Ras, et al.. (2015). Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. Oncotarget. 6(36). 38777–38788. 77 indexed citations
11.
Lanz, Henriëtte L., Johnny Suijker, Mathieu H. M. Noteborn, & Claude Backendorf. (2012). Proteasomal insensitivity of apoptin in tumor cells. Biochemical and Biophysical Research Communications. 422(1). 169–173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sakura Tamaki Breakdown of academic impact, for papers by Pauline M. Wijers‐Koster Breakdown of academic impact, for papers by Hiroo Mizobuchi Breakdown of academic impact, for papers by Satoshi Kamura Breakdown of academic impact, for papers by Robert W. Cowan Breakdown of academic impact, for papers by Masaki Shibayama Breakdown of academic impact, for papers by Lisa J. Guerrero Breakdown of academic impact, for papers by Lingyang Hua Breakdown of academic impact, for papers by Hammurabi Bartuma Breakdown of academic impact, for papers by Hideki Yoshikawa
Rankless by CCL
2026